Retrospective Study
Copyright ©The Author(s) 2019.
World J Gastroenterol. Oct 21, 2019; 25(39): 6006-6015
Published online Oct 21, 2019. doi: 10.3748/wjg.v25.i39.6006
Table 4 Overall survival for the entire patient cohort
ParametersUnivariate RR (95%CI)P valueMultivariate RR (95%CI)P value
Acute pancreatitis (yes vs no)2.47 (1.55-3.96)< 0.0012.35 (1.45-3.83)0.001
Chemotherapy, (yes vs no)0.63 (0.43-0.94)0.0240.52 (0.34-0.79)0.002
Differentiation0.002< 0.001
Moderate vs Well4.65 (1.47-14.72)0.0093.07 (0.96-9.84)0.059
Poor vs Well7.25 (2.21-23.74)0.0016.70 (2.02-22.17)0.002
T stage, T12 vs T340.51 (0.27-0.98)0.0430.781
Positive lymph nodes, (yes vs no)2.32 (1.64-3.29)< 0.0012.68 (1.83-3.92)< 0.001
Perineural invasion, (yes vs no)1.10 (0.77-1.57)0.6110.667
Vascular invasion, (yes vs no)1.44 (0.86-2.39)0.1640.430
Surgical margin, (R1 vs R0)1.41 (0.69-2.89)0.3460.728
TNM stage, (II/III vs I)2.35 (1.15-4.82)0.00.378
Sex, (male vs female)1.15 (0.81-1.62)0.4430.568
Age (< 65 yr vs ≥ 65 yr )0.96 (0.69-1.34)0.8030.694
tumor site, (distal vs head)1.52 (1.03-2.24)0.0351.90 (1.24-2.90)0.003